 |
| Quantity: | |
|---|---|
Key Advantages
• Rapid-screening within 10 minutes.
• High detection efficiency: simultaneous monitoring of IgM and IgG.
• Detection without any testing equipments .
• Easy to operate, and is compatible with serum/ plasma.
• Room-temperature storage.
Product Description
Both IgM and IgG are immunoglobulin which are produced by the immune system to provide protectionagainst the 2019-nCoV. Some patients with negative results in nucleic acid test show positive in IgM test,indicating that the IgG / IgM detection is one of the effective methods for the diagnosis of 2019-nCoV.
The level of IgM antibody begins to rise after 1 week after the initial infection, while the IgG appears later than IgM (usually in 14 days after infection) and can last for 6 months or even several years, which meansthat the IgG serves as an indicator of previous infection. Suspected patients that are infected by 2019-nCoV can be rapidly identified by simultaneous monitoring of IgM and IgG. During the outbreak period of2003-SARS and the 2016-Zika, IgM / IgG antibody detection was used as one of the recommendeddiagnostic methods.
Validation Data
Components
Key Advantages
• Rapid-screening within 10 minutes.
• High detection efficiency: simultaneous monitoring of IgM and IgG.
• Detection without any testing equipments .
• Easy to operate, and is compatible with serum/ plasma.
• Room-temperature storage.
Product Description
Both IgM and IgG are immunoglobulin which are produced by the immune system to provide protectionagainst the 2019-nCoV. Some patients with negative results in nucleic acid test show positive in IgM test,indicating that the IgG / IgM detection is one of the effective methods for the diagnosis of 2019-nCoV.
The level of IgM antibody begins to rise after 1 week after the initial infection, while the IgG appears later than IgM (usually in 14 days after infection) and can last for 6 months or even several years, which meansthat the IgG serves as an indicator of previous infection. Suspected patients that are infected by 2019-nCoV can be rapidly identified by simultaneous monitoring of IgM and IgG. During the outbreak period of2003-SARS and the 2016-Zika, IgM / IgG antibody detection was used as one of the recommendeddiagnostic methods.
Validation Data
Components
English
简体中文